Maven Securities LTD Rapt Therapeutics, Inc. Transaction History

Maven Securities LTD

  • $774 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$29.5 - $39.5 $1.48 Million - $1.98 Million
-50,000 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$29.86 - $39.47 $2.08 Million - $2.74 Million
-69,500 Reduced 58.16%
50,000 $1.55 Million
Q2 2021

Aug 16, 2021
BUY
$17.99 - $40.02 $2.15 Million - $4.78 Million
119,500 New
119,500 $3.99 Million

Others Institutions Holding RAPT

# of Institutions
104
Shares Held
27.1M
Call Options Held
26.7K
Put Options Held
2.4K
View Full List

About RAPT Therapeutics, Inc.

RAPT Quotes by TradingView
  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $24.9M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email